LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Technology Platform atbtherapeutics leverages proprietary plant-based atbiofarm technology to produce novel biologics called atbodies, which may appeal to partners interested in scalable, sustainable biologic manufacturing and innovative cancer therapeutics.

Recent Funding Boost With a recent €54 million Series A funding round led by EQT Life Sciences and a total funding of $57 million, atbtherapeutics has significant financial resources to support expansion, partnership development, and clinical pipeline advancement.

Strategic Partnerships The company's collaboration with iBio on bioengineered antibody-toxin fusion proteins indicates opportunities for joint ventures or licensing deals in novel therapeutic formats, enhancing market reach and technological capabilities.

Market Focus on Hard-to-Treat Cancers atbtherapeutics develops therapies targeting refractory and hard-to-treat cancers, creating opportunities to connect with specialty oncology centers and pharma companies looking to expand their portfolio in resistant cancer treatments.

Growing Investor Interest The company's successful Series A raises and recognition in industry news signal strong investor confidence, opening prospects for strategic investments, co-development deals, or stakeholders interested in innovative biotech ventures.

atbtherapeutics Tech Stack

atbtherapeutics uses 8 technology products and services including C3.js, Microsoft 365, Google Maps, and more. Explore atbtherapeutics's tech stack below.

  • C3.js
    Charting
  • Microsoft 365
    Email
  • Google Maps
    Maps
  • Microsoft
    Miscellaneous
  • Google Tag Manager
    Tag Management
  • Animate.css
    UI Frameworks
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers

atbtherapeutics's Email Address Formats

atbtherapeutics uses at least 1 format(s):
atbtherapeutics Email FormatsExamplePercentage
First.Last@atbtherapeutics.comJohn.Doe@atbtherapeutics.com
48%
First.MiddleLast@atbtherapeutics.comJohn.MichaelDoe@atbtherapeutics.com
2%
First.Last@atbtherapeutics.comJohn.Doe@atbtherapeutics.com
48%
First.MiddleLast@atbtherapeutics.comJohn.MichaelDoe@atbtherapeutics.com
2%

Frequently Asked Questions

Where is atbtherapeutics's headquarters located?

Minus sign iconPlus sign iconatbtherapeutics's main headquarters is located at 7 Rue de la Science Aye, Wallonia 6900 Belgium. The company has employees across 1 continents, including Europe.

What is atbtherapeutics's official website and social media links?

Minus sign iconPlus sign iconatbtherapeutics's official website is atbtherapeutics.com and has social profiles on LinkedInCrunchbase.

What is atbtherapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconatbtherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does atbtherapeutics have currently?

Minus sign iconPlus sign iconAs of February 2026, atbtherapeutics has approximately 33 employees across 1 continents, including Europe. Key team members include Ceo & Co-Founder: B. M.Coo: M. H.Head Of Downstream Processing: M. S.. Explore atbtherapeutics's employee directory with LeadIQ.

What industry does atbtherapeutics belong to?

Minus sign iconPlus sign iconatbtherapeutics operates in the Biotechnology Research industry.

What technology does atbtherapeutics use?

Minus sign iconPlus sign iconatbtherapeutics's tech stack includes C3.jsMicrosoft 365Google MapsMicrosoftGoogle Tag ManagerAnimate.cssGoogle AnalyticsNginx.

What is atbtherapeutics's email format?

Minus sign iconPlus sign iconatbtherapeutics's email format typically follows the pattern of First.Last@atbtherapeutics.com. Find more atbtherapeutics email formats with LeadIQ.

How much funding has atbtherapeutics raised to date?

Minus sign iconPlus sign icon As of February 2026, atbtherapeutics has raised $57M in funding. The last funding round occurred on Nov 18, 2024 for $57M.

When was atbtherapeutics founded?

Minus sign iconPlus sign iconatbtherapeutics was founded in 2018.

atbtherapeutics

Biotechnology ResearchWallonia, Belgium11-50 Employees

atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. 

atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. 

Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. 

The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.

Section iconCompany Overview

Headquarters
7 Rue de la Science Aye, Wallonia 6900 Belgium
Website
atbtherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $57M

    atbtherapeutics has raised a total of $57M of funding over 5 rounds. Their latest funding round was raised on Nov 18, 2024 in the amount of $57M.

  • $1M$10M

    atbtherapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $57M

    atbtherapeutics has raised a total of $57M of funding over 5 rounds. Their latest funding round was raised on Nov 18, 2024 in the amount of $57M.

  • $1M$10M

    atbtherapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    B. M.
    Ceo & Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. H.
    Coo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. S.
    Head Of Downstream Processing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. D.
    Head Of Manufacturing & Engineering
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. V.
    Director, Discovery
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    B. D.
    Director Immunology
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. K.
    Director Of Product Design
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. G.
    Lab Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. S.
    Senior Dsp Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. M.
    Senior Scientist
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.